A Note Of Explanation

I would like to provide a note of explanation regarding Marcia Clemmitt's article on scientists- turned-project managers (The Scientist, May 27, 1991, page 1). The production of high-flux neutron beams from steady-state reactors has historically set a very high standard for beam stability and reliability that those of us building the next generation of synchrotron research facilities should try to achieve for the X-ray research community. In my own case, I was trained as a neutron scatterer lo

Written byDavid Moncton
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I would like to provide a note of explanation regarding Marcia Clemmitt's article on scientists- turned-project managers (The Scientist, May 27, 1991, page 1). The production of high-flux neutron beams from steady-state reactors has historically set a very high standard for beam stability and reliability that those of us building the next generation of synchrotron research facilities should try to achieve for the X-ray research community.

In my own case, I was trained as a neutron scatterer long before taking on responsibility for the construction of the Argonne Advanced Photon Source. I did my research at the Brookhaven High- Flux Beam Reactor, where neutron beams were produced like clockwork from the time the reactor went critical in 1965 until a Department of Energy-mandated shutdown in April 1989. For the users of that facility, like myself, highly stable and reliable beams could be taken for granted, and excellent research thrived. In ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies